Call for Papers — Journal of Immunology Research and Innovation (JIRI)

Immunology

Editorial Invitation

The Journal of Immunology Research and Innovation (JIRI) invites high‑quality submissions that deepen mechanistic understanding, strengthen diagnostic and biomarker science, and move therapies from bench to bedside. We publish original research, rigorous reviews, and well‑designed short communications across clinical, translational, computational, and systems immunology. Submissions are evaluated through a double‑blind, constructive peer‑review process focused on methodological clarity, reproducibility, and real‑world relevance.

Why Publish with Journal of Immunology Research and Innovation

  • Method‑first editorial ethos: transparent reporting, robustness checks, and clear uncertainty are rewarded.
  • Constructive peer review: decision letters include actionable, prioritized guidance.
  • Open science orientation: FAIR data, executable workflows, and repository DOIs encouraged.
  • Global readership: visibility across clinical immunology, translational teams, and computational groups.

If you are interested to publish with us, submit your paper through Online Submission.

Themes of Interest (Illustrative, Not Exhaustive)

  • Immunotherapy: checkpoint blockade, CAR/TCR therapies, novel targets, resistance mechanisms, and safety (immunotoxicology).
  • Vaccine development: platforms (mRNA, viral vector, subunit), adjuvants, correlates of protection, durability, and population heterogeneity.
  • Autoimmune diseases: pathogenesis, tolerance induction, precision phenotyping, and therapeutic innovation.
  • Clinical and translational immunology: immune monitoring, trial endpoints, biomarker qualification, and real‑world evidence.
  • Computational/system immunology: multi‑omics integration, causal inference, ML/AI for prediction and interpretation.
  • In vitro and 3D immune modeling: organoids, microphysiological systems, co‑culture models, and validation against in vivo data.
  • Biomarkers and diagnostics: analytical validity, clinical validity, utility, and regulatory context of use.

Article Types We Welcome in Immunology Journal

  • Original Research (≈4,000–8,000 words): empirical or modeling studies with robust comparators and uncertainty reporting.
  • Reviews/Tutorials (≈3,000–8,000 words): critical syntheses, meta‑analyses, or method primers with standards checklists.
  • Short Communications (≈1,500–2,500 words): impactful datasets, benchmarks, pilot results, or instrument/assay notes.
  • Perspectives/Editorials: evidence‑informed commentary on methods, ethics, or future directions.

Preparing a High‑Impact Submission

  • State the question and hypothesized mechanism or clinical endpoint; explain why current approaches are insufficient.
  • Report assay details: instrument models, antibody clones, controls, calibration, and LOD/LOQ; include inter‑run reproducibility.
  • Detail computational methods: preprocessing, model architectures, hyperparameters, data splits, metrics, and interpretability.
  • Compare against strong baselines; justify metrics; show effect sizes with interval estimates; calibrate predictive models.
  • Demonstrate robustness: external validation, subgroup analyses, batch‑effect mitigation, and sensitivity to analytic choices.
  • Share artifacts: data/code DOIs, environment files or containers, and a minimal reproduction guide.
  • Communicate visually: readable figures, units and scales, color‑blind‑safe palettes, and a workflow schematic.
  • Address ethics/safety: IRB/IACUC approvals, consent/privacy, dual‑use considerations, conflicts/funding transparency.

Peer‑Review and Editorial Timeline

  • Initial screening (≈1 week): scope fit, ethics, formatting completeness.
  • Double‑blind review: two or more experts plus associate editor synthesis.
  • Decision: Accept / Minor / Major / Reject with prioritized actions.
  • Production: copyediting, metadata checks, DOI assignment, and open‑access publication.

Special Issues and Community Initiatives

JIRI welcomes Special Issue proposals on cross‑cutting themes for example, next‑generation vaccines, computational immunology standards, or immune profiling in diverse populations. Proposals (2–3 pages) should include a theme rationale, proposed guest editors with ORCIDs, candidate contributors, a timeline, and planned community activities (e.g., workshops, data challenges). We particularly encourage proposals that release open datasets, benchmarks, or inter‑comparison protocols to accelerate cumulative progress.

Submission Package Checklist

  • Cover letter: novelty, contribution, uncertainty handling, and data/code availability plan.
  • Blinded manuscript: complete Methods for replication; minimal branding with catalog numbers where needed.
  • Title page: authors, affiliations, ORCIDs, conflicts, funding sources and roles.
  • Supplement: extended methods, raw figure sources, extra tables, and a Reproduction Guide.
  • Suggested reviewers: 2–3 qualified experts without conflicts; disclose preprint DOIs and prior dissemination.

Ready to Submit?

Prepare your files and submit via our online editorial system. For pre‑submission advice on scope or fit, email a 150–200 word synopsis to the editorial office. We look forward to publishing transparent, reproducible, and impactful immunology that advances patient care and public health.

For more interesting blogs, please visit our Blog site.

Leave a Reply

Your email address will not be published. Required fields are marked *